« Older Entries
Newer Entries »
Wireless brain-spine connection to overcome paralysis
Friday, November 11th, 2016
Prof Grégoire Courtine and Dr. Jocelyne Bloch, both founders of LSP’s portfolio company G-Therapeutics, have published in Nature that a wireless brain implant – that stimulates electrodes in the leg by recreating [...]
Merus Expands Executive Management Team with the Appointment of L. Andres Sirulnik, MD, PhD, as Chief Medical Officer
Wednesday, October 26th, 2016
UTRECHT, The Netherlands, Oct. 26, 2016 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced the appointment of [...]
Curetis Announces Positive Top Line Data from U.S. FDA Trial
Tuesday, October 25th, 2016
Primary endpoint for Unyvero LRT product for lower respiratory tract infections shows overall weighted average sensitivity of 90.2% and overall weighted average specificity of 99.3%
U.S. FDA submission being [...]
Immunic acquires 4SC’s Immunology Portfolio
Wednesday, September 28th, 2016
Immunic acquires two promising drug development programs with validated targets known to be relevant in various immune and autoimmune diseases
IMU-838: New oral treatment option for Crohn’s disease
[...]
« Older Entries
Newer Entries »